XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Cash Flows [Abstract]      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 2,334,000 $ 1,525,000 $ 2,324,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities 557,000 89,000 866,000
Operating activities:      
Net income (loss) (1,190,000) 749,000 (266,000)
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of premiums and discounts on mortgage-backed securities, net 13,000 369,000 1,082,000
Stock based compensation 2,000 19,000 18,000
(Gain) loss on sale of investment securities, net 2,916,000 57,000 (1,126,000)
Unrealized (gain) loss on investment securities measured at fair value through net income, net 3,795,000 1,502,000 (319,000)
(Gain) loss on derivative instruments and other securities, net (4,630,000) (1,110,000) 2,463,000
(Increase) decrease in other assets 38,000 (29,000) 119,000
Increase (decrease) in other liabilities 69,000 (17,000) (224,000)
Net cash provided by operating activities 1,013,000 1,540,000 1,747,000
Investing activities:      
Purchases of Agency mortgage-backed securities (26,842,000) (45,345,000) (56,521,000)
Purchases of credit risk transfer and non-Agency securities (1,173,000) (2,031,000) (765,000)
Proceeds from sale of Agency mortgage-backed securities 25,978,000 34,595,000 77,294,000
Proceeds from sale of credit risk transfer and non-Agency securities 1,199,000 1,434,000 896,000
Principal collections on Agency mortgage-backed securities 6,525,000 15,042,000 17,373,000
Principal collections on credit risk transfer and non-Agency securities 209,000 84,000 131,000
Payments on U.S. Treasury securities (27,494,000) (22,055,000) (24,497,000)
Proceeds from Sale of U.S. Treasury securities 25,878,000 19,795,000 25,978,000
Net proceeds from (payments on) reverse repurchase agreements 4,001,000 1,272,000 (1,530,000)
Net proceeds from (payments on) derivative instruments 2,907,000 1,045,000 (1,834,000)
Net cash provided by investing activities 11,188,000 3,836,000 36,525,000
Financing activities:      
Proceeds from repurchase arrangements 2,360,328,000 2,189,555,000 3,133,008,000
Payments on repurchase agreements (2,371,447,000) (2,194,540,000) (3,169,824,000)
Payments on debt of consolidated variable interest entities (24,000) (49,000) (62,000)
Net proceeds from preferred stock issuance (145,000) 0 (557,000)
Net proceeds from common stock issuance 526,000 0 439,000
Payments for common stock repurchases (51,000) (281,000) (378,000)
Cash dividends paid (869,000) (860,000) (970,000)
Net cash used in financing activities (11,392,000) (6,175,000) (37,230,000)
Net change in cash and cash equivalents 809,000 (799,000) $ 1,042,000
Cash and cash equivalents at end of period $ 1,018,000 $ 998,000